GBP/USD, GBP/EUR, GBP/JPY, EUR/USD, USD/CNY, DXY
OILEX LD ORD NPV, FRONTERA RESOURCES CORPORATION ORD SHS USD0.00004 (DI), VODAFONE GROUP PLC ORD USD0.20 20/21, LLOYDS BANKING GROUP PLC ORD 10P, UK OIL & GAS PLC ORD 0.01P, MYSQUAR LIMITED ORD NPV (DI)
FTSE 100, DAX Index, Euro Stoxx 50, S&P 500, Nasdaq Composite, Nikkei 225
Gold, Silver, Crude Oil, Brent Oil, Natural Gas, Bitcoin
BTC/USD, ETH/USD, BCH/USD, XRP/USD, LTC/USD, ETC/USD
US 10Y, Euro Bund, Germany 10Y, Japan 10Y Yield, UK 10Y, India 10Y
Gold, Brent Oil, Crude Oil, CFDs on Natural Gas, Palladium, Silver
The target price of the current exchange rate is around 231 usd. We expect an ABC waveform correction from the level. The endpoint of this correction is a D1 ATR axis around 190 usd. There is a further rise in the level of this level.
Shares of Amgen may be forming a bearish head and shoulder pattern. In the case the neckline is broken, price could fall within weeks to below $150.00. However we must take into account that Amgen share price is not currently in a bearish trend, but a long bullish one. This is a pattern formation that is being put on watch, in case it breaks. Once the share price ...
22nd Nov - Decent Pullback. DB formed. RSI OverSold - Looking for Calls Options 175 + Jan, Feb, March
I don't usually trade biotech, however, AMGEN is looking like a buy to me. Showing rejection from the 200ma with a bullish engulfing bar.
RSI was previously oversold at the 200ma along with the Stoch.
Strong fundamentals. One downgrade from Argus but most ratings still targeting 188-198.
Stop - 167
TP1 - 188
TP2 - 200